MKI67 and tuberculosis: Assessing the expression of the activation and proliferation markers CD38, HLA-DR and Ki-67 can assist in discriminating between ATB and latent TB infection (LTBI) and can be used for monitoring TB treatment response [10,11,12,13,14,15] and, potentially, for the early detection of TB disease progression [16].